Published in J Mol Med (Berl) on October 14, 2004
Chronic fatigue syndrome is associated with diminished intracellular perforin. Clin Exp Immunol (2005) 1.24
Cystatins in immune system. J Cancer (2012) 1.22
Neuroendocrine and immune contributors to fatigue. PM R (2010) 0.97
Exercise responsive genes measured in peripheral blood of women with chronic fatigue syndrome and matched control subjects. BMC Physiol (2005) 0.92
A gene signature for post-infectious chronic fatigue syndrome. BMC Med Genomics (2009) 0.90
Reduced levels of oestrogen receptor beta mRNA in Swedish patients with chronic fatigue syndrome. J Clin Pathol (2006) 0.84
Determination of quantitative and site-specific DNA methylation of perforin by pyrosequencing. BMC Res Notes (2009) 0.81
GB virus-C--a virus without a disease: we cannot give it chronic fatigue syndrome. BMC Infect Dis (2005) 0.79
Acute psychosocial stress-mediated changes in the expression and methylation of perforin in chronic fatigue syndrome. Genet Epigenet (2013) 0.75
Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2007) 13.20
Prevalence of HPV infection among females in the United States. JAMA (2007) 10.55
Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National Health and Nutrition Examination Surveys, 2003-2010. J Infect Dis (2013) 6.04
Identification of ambiguities in the 1994 chronic fatigue syndrome research case definition and recommendations for resolution. BMC Health Serv Res (2003) 4.93
Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2014) 4.50
Prevalence and incidence of chronic fatigue syndrome in Wichita, Kansas. Arch Intern Med (2003) 4.46
Assuring the quality of next-generation sequencing in clinical laboratory practice. Nat Biotechnol (2012) 3.62
Seroprevalence of human papillomavirus type 16 infection in the United States. J Infect Dis (2002) 3.42
Cytokine milieu of atopic dermatitis skin subverts the innate immune response to vaccinia virus. Immunity (2006) 3.39
Human papillomavirus infection and cervical cytology in women screened for cervical cancer in the United States, 2003-2005. Ann Intern Med (2008) 2.98
Chronic fatigue syndrome--a clinically empirical approach to its definition and study. BMC Med (2005) 2.97
Prevalence of genital human papillomavirus among females in the United States, the National Health And Nutrition Examination Survey, 2003-2006. J Infect Dis (2011) 2.88
Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep (2015) 2.73
Prevalence of chronic fatigue syndrome in metropolitan, urban, and rural Georgia. Popul Health Metr (2007) 2.58
The economic impact of chronic fatigue syndrome. Cost Eff Resour Alloc (2004) 2.47
Seroprevalence of human papillomavirus types 6, 11, 16, and 18 in the United States: National Health and Nutrition Examination Survey 2003-2004. J Infect Dis (2009) 2.43
Selective killing of vaccinia virus by LL-37: implications for eczema vaccinatum. J Immunol (2004) 2.16
Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study. BMJ (2006) 2.14
A formal analysis of cytokine networks in chronic fatigue syndrome. Brain Behav Immun (2010) 1.95
Psychometric properties of the CDC Symptom Inventory for assessment of chronic fatigue syndrome. Popul Health Metr (2005) 1.94
Integrated weighted gene co-expression network analysis with an application to chronic fatigue syndrome. BMC Syst Biol (2008) 1.93
A population-based study of the clinical course of chronic fatigue syndrome. Health Qual Life Outcomes (2003) 1.80
The effect of correct and consistent condom use on chlamydial and gonococcal infection among urban adolescents. Arch Pediatr Adolesc Med (2005) 1.78
Simultaneous amplification and identification of 25 human papillomavirus types with Templex technology. J Clin Microbiol (2006) 1.75
Psychiatric comorbidity in persons with chronic fatigue syndrome identified from the Georgia population. Psychosom Med (2009) 1.69
Association of Chlamydia trachomatis with persistence of high-risk types of human papillomavirus in a cohort of female adolescents. Am J Epidemiol (2005) 1.67
Efficient DNA extraction for HPV genotyping in formalin-fixed, paraffin-embedded tissues. J Mol Diagn (2011) 1.64
Individual and geographic disparities in human papillomavirus types 16/18 in high-grade cervical lesions: Associations with race, ethnicity, and poverty. Cancer (2013) 1.64
Cervical cancer incidence in a prevaccine era in the United States, 1998-2002. Obstet Gynecol (2007) 1.60
Are chronic fatigue and chronic fatigue syndrome valid clinical entities across countries and health-care settings? Aust N Z J Psychiatry (2009) 1.57
Epidemiologic and viral factors associated with cervical neoplasia in HPV-16-positive women. Int J Cancer (2005) 1.51
Autologous Epstein-Barr virus (EBV)-specific cytotoxic T cells for the treatment of persistent active EBV infection. Blood (2002) 1.40
Epidemiology of human papillomavirus infection and abnormal cytologic test results in an urban adolescent population. J Infect Dis (2003) 1.39
Pre-event smallpox vaccination and postevent exposure and disease: a report of the Joint Task Force on Smallpox Vaccination for Allergists. Ann Allergy Asthma Immunol (2005) 1.38
Childhood trauma and risk for chronic fatigue syndrome: association with neuroendocrine dysfunction. Arch Gen Psychiatry (2009) 1.32
Early adverse experience and risk for chronic fatigue syndrome: results from a population-based study. Arch Gen Psychiatry (2006) 1.31
Prevalence of human papillomavirus types in invasive vulvar cancers and vulvar intraepithelial neoplasia 3 in the United States before vaccine introduction. J Low Genit Tract Dis (2012) 1.26
Post-licensure monitoring of HPV vaccine in the United States. Vaccine (2010) 1.24
Combinations of single nucleotide polymorphisms in neuroendocrine effector and receptor genes predict chronic fatigue syndrome. Pharmacogenomics (2006) 1.23
Human papillomavirus infection and cytologic abnormalities of the anus and cervix among HIV-infected women in the study to understand the natural history of HIV/AIDS in the era of effective therapy (the SUN study). Sex Transm Dis (2011) 1.21
Utility of the blood for gene expression profiling and biomarker discovery in chronic fatigue syndrome. Dis Markers (2002) 1.20
Inclusion of the glucocorticoid receptor in a hypothalamic pituitary adrenal axis model reveals bistability. Theor Biol Med Model (2007) 1.18
A real-time PCR assay for HPV52 detection and viral load quantification. Clin Lab (2012) 1.18
Higher heart rate and reduced heart rate variability persist during sleep in chronic fatigue syndrome: a population-based study. Auton Neurosci (2007) 1.15
DNA and RNA references for qRT-PCR assays in exfoliated cervical cells. J Mol Diagn (2006) 1.15
Attenuated morning salivary cortisol concentrations in a population-based study of persons with chronic fatigue syndrome and well controls. J Clin Endocrinol Metab (2007) 1.14
Primary and secondary prevention of cervical cancer--opportunities and challenges. J Natl Cancer Inst (2009) 1.13
Human papillomavirus genotypes in high-grade cervical lesions in the United States. J Infect Dis (2012) 1.12
Factor analysis of symptoms among subjects with unexplained chronic fatigue: what can we learn about chronic fatigue syndrome? J Psychosom Res (2004) 1.12
Population impact of HPV vaccines: summary of early evidence. J Adolesc Health (2013) 1.12
Human papillomavirus and molecular considerations for cancer risk. Cancer (2008) 1.12
Human papillomavirus (HPV) 6, 11, 16, and 18 prevalence among females in the United States--National Health And Nutrition Examination Survey, 2003-2006: opportunity to measure HPV vaccine impact? J Infect Dis (2011) 1.11
Integration of gene expression, clinical, and epidemiologic data to characterize Chronic Fatigue Syndrome. J Transl Med (2003) 1.10
Polymorphisms in genes regulating the HPA axis associated with empirically delineated classes of unexplained chronic fatigue. Pharmacogenomics (2006) 1.10
Gene expression profile of empirically delineated classes of unexplained chronic fatigue. Pharmacogenomics (2006) 1.10
Neuroendocrine and immune network re-modeling in chronic fatigue syndrome: an exploratory analysis. Genomics (2008) 1.09
Genetic evaluation of the serotonergic system in chronic fatigue syndrome. Psychoneuroendocrinology (2008) 1.08
Neurocognitive and functional outcomes in persons recovering from West Nile virus illness. J Neuropsychol (2008) 1.06
Alterations in diurnal salivary cortisol rhythm in a population-based sample of cases with chronic fatigue syndrome. Psychosom Med (2008) 1.06
Barriers to healthcare utilization in fatiguing illness: a population-based study in Georgia. BMC Health Serv Res (2009) 1.06
Sensitive and specific peak detection for SELDI-TOF mass spectrometry using a wavelet/neural-network based approach. PLoS One (2012) 1.06
Seroprevalence of human papillomavirus type 16 in children. J Infect Dis (2005) 1.06
Complement activation in a model of chronic fatigue syndrome. J Allergy Clin Immunol (2003) 1.05
Sleep characteristics of persons with chronic fatigue syndrome and non-fatigued controls: results from a population-based study. BMC Neurol (2006) 1.05
CDC grand rounds: Reducing the burden of HPV-associated cancer and disease. MMWR Morb Mortal Wkly Rep (2014) 1.05
Assessing the relationship between HIV infection and cervical cancer in Côte d'Ivoire: a case-control study. BMC Infect Dis (2010) 1.05
Identifying illness parameters in fatiguing syndromes using classical projection methods. Pharmacogenomics (2006) 1.05
Type-specific reproducibility of the Roche linear array HPV genotyping test. J Clin Virol (2008) 1.04
Human papillomavirus prevalence in oropharyngeal cancer before vaccine introduction, United States. Emerg Infect Dis (2014) 1.04
Molecular quality of exfoliated cervical cells: implications for molecular epidemiology and biomarker discovery. Cancer Epidemiol Biomarkers Prev (2004) 1.04
Impaired immune function in Gulf War Illness. BMC Med Genomics (2009) 1.03
Gene expression correlates of unexplained fatigue. Pharmacogenomics (2006) 1.03
Evaluation of the rapid BioStar optical immunoassay for detection of Chlamydia trachomatis in adolescent women. J Clin Microbiol (2008) 1.03
Impact of human papillomavirus (HPV) vaccination on HPV 16/18-related prevalence in precancerous cervical lesions. Vaccine (2012) 1.03
Quantitation of site-specific HPV 16 DNA methylation by pyrosequencing. J Virol Methods (2006) 1.02
Human papillomavirus prevalence in invasive anal cancers in the United States before vaccine introduction. J Low Genit Tract Dis (2013) 1.02
National registry for juvenile-onset recurrent respiratory papillomatosis. Arch Otolaryngol Head Neck Surg (2003) 1.02
Personality features and personality disorders in chronic fatigue syndrome: a population-based study. Psychother Psychosom (2010) 1.02
Performance of commercial reverse line blot assays for human papillomavirus genotyping. J Clin Microbiol (2012) 1.01
Evidence of inflammatory immune signaling in chronic fatigue syndrome: A pilot study of gene expression in peripheral blood. Behav Brain Funct (2008) 1.00
Human papillomavirus type 16 E2 and E6/E7 variants. Gynecol Oncol (2005) 1.00
Prevalence of cervical and oral human papillomavirus infections among US women. J Infect Dis (2013) 0.99
Regional distribution of fatiguing illnesses in the United States: a pilot study. Popul Health Metr (2004) 0.98